MC2 Therapeutics A/S Financials, key figures and credit report
Gross profit 43 233.9 kDKK FY 2025 +14,598.7% vs 2024
EBIT 14 759.1 kDKK FY 2025 +143.9% vs 2024
Net debt 258 362.3 kDKK FY 2025 -1.9% vs 2024
Quick ratio 1.1 FY 2025 -1.3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -4 727.29 | -74 371.73 | 576.83 | - 298.19 | 43 233.90 |
| Employee benefit expenses | -31 462.75 | -29 368.25 | -32 616.86 | -31 851.26 | -27 230.98 |
| Other operating expenses | -17.03 | ||||
| Total depreciation | - 703.50 | -1 540.16 | -1 508.69 | -1 477.19 | -1 226.78 |
| EBIT | -36 893.54 | - 105 280.13 | -33 548.72 | -33 626.64 | 14 759.12 |
| Other financial income | 224.30 | 1 972.22 | 5 477.94 | 3 866.39 | 13 816.77 |
| Other financial expenses | -3 102.65 | -8 295.99 | -19 726.37 | -30 650.88 | -36 360.51 |
| Pre-tax profit | -39 771.89 | - 111 603.90 | -47 797.15 | -60 411.13 | -7 784.62 |
| Income taxes | 14 548.93 | 10 189.17 | 5 928.25 | 7 388.76 | 18.81 |
| Net earnings | -25 222.96 | - 101 414.73 | -41 868.90 | -53 022.37 | -7 765.81 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 5 702.43 | 4 819.94 | 4 400.51 | 3 976.78 | 3 182.60 |
| Machinery and equipment | 2 774.48 | 2 232.09 | 1 781.03 | 1 373.64 | 950.95 |
| Tangible assets total | 8 476.91 | 7 052.03 | 6 181.54 | 5 350.43 | 4 133.55 |
| Investments total | 271.58 | 271.58 | 444.00 | 455.10 | 336.15 |
| Long term receivables total | |||||
| Finished products/goods | 5 354.66 | 11 029.32 | 13 935.71 | 18 294.02 | 22 075.76 |
| Advance payments | 4 481.84 | ||||
| Inventories total | 5 354.66 | 15 511.16 | 13 935.71 | 18 294.02 | 22 075.76 |
| Current trade debtors | 5 238.22 | 14 471.79 | 7 691.61 | 52 118.70 | 36 729.32 |
| Prepayments and accrued income | 899.13 | 13 676.36 | 5 593.40 | 2 108.08 | 232.83 |
| Current other receivables | 9 595.02 | 4 919.53 | 1 795.72 | 1 644.43 | 3 935.85 |
| Current deferred tax assets | 19 534.90 | 19 133.14 | 6 003.13 | 13 771.77 | |
| Short term receivables total | 35 267.26 | 52 200.83 | 21 083.86 | 69 642.99 | 40 897.99 |
| Cash and bank deposits | 18 591.30 | 8 628.49 | 15 997.05 | 16 269.01 | 18 906.36 |
| Cash and cash equivalents | 18 591.30 | 8 628.49 | 15 997.05 | 16 269.01 | 18 906.36 |
| Balance sheet total (assets) | 67 961.71 | 83 664.08 | 57 642.16 | 110 011.54 | 86 349.82 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 6 611.48 | 6 611.48 | 6 611.48 | 6 611.48 | 6 611.48 |
| Retained earnings | -2 486.13 | -27 846.70 | - 129 276.44 | - 172 075.61 | - 223 324.60 |
| Profit of the financial year | -25 222.96 | - 101 414.73 | -41 868.90 | -53 022.37 | -7 765.81 |
| Minority interest (BS) | -83.48 | - 101.30 | - 116.74 | - 135.60 | |
| Shareholders equity total | -21 097.61 | - 122 733.43 | - 164 635.15 | - 218 603.23 | - 224 614.52 |
| Provisions | 3 000.59 | ||||
| Non-current advances received | 3 856.87 | 8 578.82 | 5 766.02 | ||
| Non-current trade creditors | 17 430.50 | ||||
| Non-current owed to group member | 19 131.81 | 156 317.29 | 189 574.61 | 270 718.61 | 247 268.68 |
| Non-current deferred tax liabilities | 914.03 | 837.61 | 873.92 | 898.95 | 936.67 |
| Non-current liabilities total | 20 045.84 | 178 442.27 | 199 027.35 | 271 617.57 | 253 971.37 |
| Current loans from credit institutions | 9 000.00 | 30 000.00 | |||
| Advances received | 503.07 | 4 425.32 | 20 997.00 | 1 326.21 | |
| Current trade creditors | 42 393.74 | 26 422.49 | 17 317.76 | 24 264.22 | 21 986.36 |
| Other non-interest bearing current liabilities | 26 619.74 | 1 029.67 | 1 506.89 | 2 735.98 | 679.82 |
| Current liabilities total | 69 013.48 | 27 955.23 | 23 249.97 | 56 997.20 | 53 992.39 |
| Balance sheet total (liabilities) | 67 961.71 | 83 664.08 | 57 642.16 | 110 011.54 | 86 349.82 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated